Rakesh Jain - Tekla Healthcare Insider

XHQHX -- USA Fund  

USD 24.89  0.02  0.08%

  Executive
Dr. Rakesh K. Jain, Ph.D., is an Independent Trustee of HQ Healthcare Investors. Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing each Fund with a valuable perspective on emerging life sciences technologies. Dr. Jain cofounded XTuit Pharmaceuticals, Inc. in 2011, where he also serves as a board member. He serves on the Governance and Nominating Committee of each Fund. Prior to joining Harvard, he was professor of chemical engineering at Columbia University and Carnegie Mellon University. Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. Dr. Jain has authored more than 600 publications. He serves on advisory panels to government, industry and academia, and has served or continues to serve on editorial advisory boards of twenty journals, including Journal of Clinical Oncology and Nature Reviews Clinical Oncology. He has received more than 70 major awards and lectureships, including a Guggenheim Fellowship, the Humboldt Senior Scientist Award, the National Cancer Institute Research Career Development Award and Outstanding Investigator Grant, the Academic Scientist of the Year Award from the Pharmaceutical Achievements Awards, the Distinguished Service Award from Nature Biotechnology and the Innovator Award from the DoD Breast Cancer Program. He is a member of all three branches of US National Academies the Institute of Medicine, the National Academy of Engineering and the National Academy of Sciences and is a member of the American Academy of Arts and Sciences.
Age: 66  Executive Since 2007      

Management Performance (%)

Similar Money Managers

Found 12 records

One Year Return

Alan WilsonAmerican Funds Growth Fund of A
-5.55%
John SmetAmerican Funds American Balance
4.11%
Paul BenjaminAmerican Funds American Balance
4.11%
Alan WilsonAmerican Funds Growth Fund of A
0.0%
Paul BenjaminAmerican Funds American Balance
0.0%
Carl KawajaAmerican Funds Europacific Grow
-8.54%
John SmetAmerican Funds American Balance
0.0%
Carl KawajaAmerican Funds Europacific Grow
-14.05%
Alan WilsonAmerican Funds Growth Fund of A
-0.11%
Michael PerreVanguard Total Intl Stock Idx I
0.0%
Carl KawajaAmerican Funds Europacific Grow
-10.42%
Alan WilsonAmerican Funds Growth Fund of A
-0.08%

Fund Summary

The fund is listed under null category and is part of null family.

Tekla Healthcare Inv Leadership Team

William Reardon, Independent Trustee
Michael Bonney, Independent Trustee
Oleg Pohotsky, Independent Chairman of the Board of Trustees
Laura Woodward, Chief Compliance Officer, Treasurer, Secretary
Lucinda Stebbins, Independent Trustee
Daniel Omstead, President Trustee
Uwe Reinhardt, Independent Trustee
Rakesh Jain, Independent Trustee

Fund Performance Indicators

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Portfolio Rebalancing

Also Currentnly Active

Purchased over 400 shares of
few hours ago
Traded for 6.36
Purchased a lot of shares of
few hours ago
Traded for 153.4
Purchased few shares of
few hours ago
Traded for 1161.22
See also Your Current Watchlist. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Search macroaxis.com